Description | APC anti-human HLA-DR. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kD α (heavy) chain and a 27 kD β (light) chain. It is expressed on B cells, activated T cells, monocytes/macrophages, dendritic cells, and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4 T cells. |
Product Specific References | PubMed: 22942426, 25188438, 25568177, 25883388, 26162403, 26471483, 27103745, 26957562, 28886135, 29615603, 29456740, 28765265, 30135583, 30674883, 30787276, 30890164, 29752277, 30674883, 31533030, 29615676, 32668238, 31914379, 30555458, 33348809, 33296701, 33082328, 32971982, 33666760, 33835029, 33296701, 33891889, 34095863 |